Cypherpunk Technologies (NASDAQ:CYPH) Share Price Crosses Below Fifty Day Moving Average – Here’s What Happened

Cypherpunk Technologies (NASDAQ:CYPH) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.69 and traded as low as $0.6635. Cypherpunk Technologies shares last traded at $0.68, with a volume of 801,697 shares trading hands.

Analyst Ratings Changes

CYPH has been the topic of a number of research analyst reports. Weiss Ratings downgraded Cypherpunk Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, July 31st. Cantor Fitzgerald upgraded Cypherpunk Technologies to a “strong-buy” rating in a research report on Friday, July 3rd. Finally, Wall Street Zen raised Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $0.90.

Cypherpunk Technologies Price Performance

The firm’s 50-day moving average price is $0.68 and its 200 day moving average price is $0.78.

Cypherpunk Technologies (NASDAQ:CYPH) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.18 earnings per share (EPS) for the quarter.

Institutional Trading of Cypherpunk Technologies

A number of large investors have recently made changes to their positions in the stock. Millennium Management LLC acquired a new position in Cypherpunk Technologies in the 4th quarter valued at about $37,000. LPL Financial LLC acquired a new stake in shares of Cypherpunk Technologies during the 4th quarter worth about $38,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Cypherpunk Technologies during the 4th quarter worth about $44,000. Sequoia Financial Advisors LLC purchased a new stake in shares of Cypherpunk Technologies during the fourth quarter worth about $56,000. Finally, HighTower Advisors LLC purchased a new stake in shares of Cypherpunk Technologies during the fourth quarter worth about $59,000. Institutional investors and hedge funds own 30.46% of the company’s stock.

Cypherpunk Technologies Company Profile

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.